+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Depyrogenated Sterile Empty Vials Market By Product (2 ml, 5 ml, 10 ml, 20 ml, and more than 20 ml) and End-use (Compounding Labs, Clinical Labs, and Pharmaceutical Manufacturers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

  • ID: 5143525
  • Report
  • November 2019
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2
The report covers forecast and analysis for the depyrogenated sterile empty vials market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the depyrogenated sterile empty vials market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the depyrogenated sterile empty vials market on a global as well as regional level.

According to the report, global demand for depyrogenated sterile empty vials market was valued at approximately USD 749.4 Million in 2018, and is expected to generate revenue of around USD 1,257.4 Million by end of 2025, growing at a CAGR of around 7.8% between 2019 and 2025.

In order to give the users of this report a comprehensive view on the depyrogenated sterile empty vials market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the depyrogenated sterile empty vials market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the depyrogenated sterile empty vials market on global and regional basis.

Depyrogenation is the removal of pyrogens from solution, most frequently from injectable pharmaceuticals. A pyrogen can be defined as any substance that can cause a fever. Bacterial pyrogens include endotoxins and exotoxins, although many pyrogens are endogenous to the host.

Factors such as technological improvements in manufacturing process of vial, introduction of innovative vials, manufacturing of affordable vials, and increasing demand for compounding labs to make personalized medicine will act as major driving factors in the growth of global depyrogenated sterile empty vials market. Increasing demand for personalized medicine and investment in research and development will act as an opportunity for the market players in the depyrogenated sterile empty vials market. Nonetheless, increasing demand for alternative parenteral packaging will restrict the growth of global depyrogenated sterile empty vials market.

The global depyrogenated sterile empty vials market has been split into product, end-use, and region. Based on product, depyrogenated sterile empty vials market has been segmented into 2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml. The 20 ml segment accounted for the highest market share in 2018 due to high demand. The end-use segment has been segmented into compounding labs, clinical labs, and pharmaceutical manufacturers. The compounding labs segment accounted for the highest market share in 2018 due to increasing demand for personalized medicine.

North America will be the leading region during the forecast period. Increasing incidence of non-communicable and communicable diseases and rapid uptake of latest technologies will boost the market growth in this region. Europe is expected to be the second major market. The key reasons are presence of skilled researchers and presence of key manufacturers. Asia Pacific will grow at rapid rate over the forecast time-frame due to increasing number of research laboratories, growing prevalence of infectious diseases. The market in Latin America will grow at a substantial rate during the estimate period. The Africa and Middle Eastern region is expected to exhibit definite progression in the anticipated time-frame.

The report also includes detailed profiles of key players such as Corning Incorporated, Thermo Fisher Scientific, APG Pharma, DWK Life Sciences, VWR International, Nipro PharmaPackaging, Gerresheimer, Merck KGaA, Radpharm Scientific, Stevanato Group, SCHOTT among others.

This report segments the Global Depyrogenated Sterile Empty Vials Market as follows:

Global Depyrogenated Sterile Empty Vials Market: By Product
  • 2 ml
  • 5 ml
  • 10 ml
  • 20 ml
  • More than 20 ml
Global Depyrogenated Sterile Empty Vials Market: By End-use
  • Compounding Labs
  • Clinical Labs
  • Pharmaceutical Manufacturers
Global Depyrogenated Sterile Empty Vials Market: By Region
  • North America
  • The U.S.
  • Canada
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Depyrogenated Sterile Empty Vials Market, 2016–2025 (USD Million)
    • 2.2. Depyrogenated Sterile Empty Vials Market: Snapshot
  • Chapter 3. Depyrogenated Sterile Empty Vials Market – Industry Analysis
    • 3.1. Depyrogenated Sterile Empty Vials Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Technulogical improvements in manufacturing process of vial
      • 3.2.2. Introduction of innovative vials
    • 3.3. Restraint
      • 3.3.1. Increasing demand for alternative parenteral packaging
    • 3.4. Opportunities
      • 3.4.1. Increasing demand for personalized medicine
      • 3.4.2. Investment in research and development
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By End-use
      • 3.6.3. Market attractiveness analysis by Region
  • Chapter 4. Depyrogenated Sterile Empty Vials Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Depyrogenated Sterile Empty Vials Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Depyrogenated Sterile Empty Vials Market –Product Analysis
    • 5.1. Global Depyrogenated Sterile Empty Vials Market overview: By Product
      • 5.1.1. Global Depyrogenated Sterile Empty Vials Market share, By Product,2018 and 2025
    • 5.2. 2 ml
      • 5.2.1. Global Depyrogenated Sterile Empty Vials Market by 2 ml, 2016–2025 (USD Million)
    • 5.3. 5 ml
      • 5.3.1. Global Depyrogenated Sterile Empty Vials Market by 5 ml, 2016–2025 (USD Million)
    • 5.4. 10 ml
      • 5.4.1. Global Depyrogenated Sterile Empty Vials Market by 10 ml, 2016–2025 (USD Million)
    • 5.5. 20 ml
      • 5.5.1. Global Depyrogenated Sterile Empty Vials Market by 20 ml, 2016–2025 (USD Million)
    • 5.6. More than 20 ml
      • 5.6.1. Global Depyrogenated Sterile Empty Vials Market by More than 20 ml, 2016–2025 (USD Million)
  • Chapter 6. Global Depyrogenated Sterile Empty Vials Market –End-use Analysis
    • 6.1. Global Depyrogenated Sterile Empty Vials Market overview: By End-use
      • 6.1.1. Global Depyrogenated Sterile Empty Vials Market share, By End-use, 2018 and 2025
    • 6.2. Compounding Labs
      • 6.2.1. Global Depyrogenated Sterile Empty Vials Market By Compounding Labs, 2016–2025 (USD Million)
    • 6.3. Clinical Labs
      • 6.3.1. Global Depyrogenated Sterile Empty Vials Market By Clinical Labs, 2016–2025 (USD Million)
    • 6.4. Pharmaceutical Manufacturers
      • 6.4.1. Global Depyrogenated Sterile Empty Vials Market By Pharmaceutical Manufacturers, 2016–2025 (USD Million)
  • Chapter 7. Global Depyrogenated Sterile Empty Vials Market - Regional Analysis
    • 7.1. Global Depyrogenated Sterile Empty Vials Market overview: by Region
      • 7.1.1. Global Depyrogenated Sterile Empty Vials Market share, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Depyrogenated Sterile Empty Vials Market, 2016–2025 (USD Million)
      • 7.2.2. North America Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
      • 7.2.3. North America Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.2.4.2. U.S. Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.2.5.2. Rest of North America Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Depyrogenated Sterile Empty Vials Market, 2016–2025 (USD Million)
      • 7.3.2. Europe Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
      • 7.3.3. Europe Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. U.K. Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.3.4.2. U.K. Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.3.5.2. France Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.3.6.2. Germany Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.3.7.2. Rest of Europe Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Depyrogenated Sterile Empty Vials Market, 2016–2025 (USD Million)
      • 7.4.2. Asia Pacific Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
      • 7.4.3. Asia Pacific Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.4.4.2. China Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.4.5.2. Japan Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.4.6.2. India Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Depyrogenated Sterile Empty Vials Market, 2016–2025 (USD Million)
      • 7.5.2. Latin America Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
      • 7.5.3. Latin America Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.5.4.2. Brazil Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
        • 7.5.5.2. Rest of Latin America Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Depyrogenated Sterile Empty Vials Market, 2016–2025 (USD Million)
      • 7.6.2. The Middle East and Africa Depyrogenated Sterile Empty Vials Market revenue, By Product,2016–2025 (USD Million)
      • 7.6.3. The Middle East and Africa Depyrogenated Sterile Empty Vials Market revenue, By End-use, 2016–2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Corning Incorporated
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Thermo Fisher Scientific
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. APG Pharma
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. DWK Life Sciences
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. VWR International
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Nipro PharmaPackaging
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Gerresheimer
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Merck KGaA
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Radpharm Scientific
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Stevanato Group
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. SCHOTT
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
Note: Product cover images may vary from those shown
Adroll
adroll